The region’s biotech companies are resilient, but being tested by a federal funding landscape that looks a lot less certain than in the past.
The region’s biotech companies are resilient, but being tested by a federal funding landscape that looks a lot less certain than in the past.
Sign up for our daily digest of everything you need to know about San Diego — just the essentials, every morning.
By clicking sign up, you agree to the terms.